embecta corp shares are up after the company on monday beat wall street expectations in its third quarter shares were recently trading at 3267 up almost 14 the parsippany njbased manufacturer of medical devices used in the treatment of diabetes said net income fell to 624 million compared with 1047 million in the previous year on a pershare basis the company posted earnings of 107 beating factset analysts estimates of 87 cents a share revenue fell to 2911 million from 295 million in the yearago quarter analysts polled by factset were expecting revenue of 2769 million on a constant currency basis revenue was up 2 yearoveryear the company said the company which completed its spinoff from becton dickinson  co in april of this year has seen its share price rise almost 30 in the last three months